“Approved” refers to a particular product
The US agency that reviews drugs is FDA, short for Food and Drug Administration.
As of September 26, 2026, approved products with specific uses include Ozempic and Wegovy (semaglutide), plus Mounjaro and Zepbound (tirzepatide). [a]
FDA approval of one product does not approve every peptide product. [a]
“Registered” is a different claim
Registering means listing a drug-making site with FDA. As of September 26, 2026, this does not mean FDA has approved its medicines or that every product may be sold legally. [b]
A National Drug Code, called an NDC, is a number used to identify a medicine in a government drug directory. [c]
An NDC number does not establish drug approval, according to FDA as of September 26, 2026. [c]
Ask the doctor or pharmacist to show you the exact medicine’s entry in FDA’s Drugs@FDA approval search. Match the name and whether it is a shot, tablet or another form.
“Generic” does not mean made to order
A generic has approval as a version of a brand medicine. Preparing medicine to order is called compounding.
As of September 26, 2026, the United States has no approved generic of semaglutide or tirzepatide that may legally be sold. [a]
Describing a custom medicine as an approved generic is false or misleading, FDA says. [d]
“It was in shortage” needs a current check
Neither semaglutide nor tirzepatide injections appear on FDA’s shortage list as of September 26, 2026. [e]
FDA’s shortage list covers national supply problems. A local stock gap does not permit a pharmacy to make a copy under the national shortage rules. [e]
Keep the date with the claim. Ask for an explanation if the advert relies on an old shortage.